The study aimed to investigate the prevalence, treatment, and outcomes of upper extremity deep vein thrombosis (UE-DVT) in hospitalized patients over a two-year period.
Out of 63,045 hospitalized patients, 1,000 (1.6%) were diagnosed with UE-DVT, most of whom were middle-aged men with a significant number having IV devices in place.
In-hospital complications included a 12.1% mortality rate, 47.6% experiencing major bleeding, and a 6.1% rate of recurrent UE-DVT after treatment, with factors like older age and cancer increasing the risk of mortality.